Patents by Inventor Pei-Han CHUNG

Pei-Han CHUNG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210309732
    Abstract: Disclosed herein are anti-GM-CSF antibodies capable of binding to human GM-CSF and blocking its biological activities. Also provided herein are pharmaceutical compositions comprising the anti-GM-CSF antibodies and therapeutic and diagnostic uses of such antibodies.
    Type: Application
    Filed: March 10, 2021
    Publication date: October 7, 2021
    Applicant: ELIXIRON IMMUNOTHERAPEUTICS (HONG KONG) LIMITED
    Inventors: Cheng-Lun KU, Yu-Fang LO, Han-Po SHIH, Jing-Ya DING, Pei-Han CHUNG, Yin-Ping WANG
  • Patent number: 10813974
    Abstract: The present invention provides methods for treating hepatitis B virus (HBV) infection using antibodies which specifically bind to human IFN?.
    Type: Grant
    Filed: June 1, 2020
    Date of Patent: October 27, 2020
    Assignee: ELIXIRON IMMUNOTHERAPEUTICS (HONG KONG) LIMITED
    Inventors: Hung-Kai Chen, Daw-Tsun Shih, Cheng-Lun Ku, Pei-Han Chung
  • Publication number: 20200289603
    Abstract: The present invention provides methods for treating hepatitis B virus (HBV) infection using antibodies which specifically bind to human IFN?.
    Type: Application
    Filed: June 1, 2020
    Publication date: September 17, 2020
    Applicant: ELIXIRON IMMUNOTHERAPEUTICS (HONG KONG) LIMITED
    Inventors: Hung-Kai CHEN, Daw-Tsun SHIH, Cheng-Lun KU, Pei-Han CHUNG